Vancouver, British Columbia – July 30, 2025 – TheNewswire - Orion Nutraceuticals Inc., (CSE: ORI) (the “Company” or “Orion”) announces that it has received approval from the Canadian Securities Exchange (the “CSE”) to voluntarily delist its common shares from the CSE. The Company expects the delisting to become effective at the close of trading on July 30, 2025.

 

Following the delisting, the Company will remain a reporting issuer in the provinces of British Columbia and Ontario and will continue to comply with its continuous disclosure obligations under applicable securities laws in those jurisdictions.

 

The decision to delist from the CSE was made after careful consideration of the Company's current operational needs, trading volumes, and the costs associated with maintaining a listing. The Company believes that the delisting is in the best interests of the Company and its shareholders.

 

Shareholders are encouraged to consult with their investment advisors regarding the implications of the delisting.

About Orion Nutraceuticals Inc.

Orion Nutraceuticals Inc. is actively evaluating potential investment and acquisition opportunities.

ON BEHALF OF THE BOARD

Guy Bourgeois, Director
Tel: (604) 687-2038

The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this news release.

 

Forward-Looking Statements

This news release contains "forward-looking information" and "forward-looking statements" (collectively, “forward-looking statements”) within the meaning of applicable securities laws, including statements regarding the Company’s intention to delist from CSE, the anticipated benefits of the Delisting, the Company’s ongoing obligations as a reporting issuer, and the potential impact on shareholders and trading liquidity. Forward-looking statements are based on the opinions, assumptions and estimates of management as of the date they are made and are subject to various known and unknown risks and uncertainties.

These risks include, but are not limited to, changes in market conditions, regulatory developments, the Company’s ability to maintain compliance with applicable laws, and other factors that may cause actual outcomes to differ materially from those expressed or implied by such forward-looking statements.

Readers are cautioned not to place undue reliance on forward-looking statements. Except as required by applicable law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.